Unfortunately, clinical evaluation and diagnostic tests sometimes fail to determine whether a necrotizing myopathy is immune mediated, resulting in undertreatment of autoimmune myopathies or ...
[12] The proportion developing myopathy on introduction of other statins among patients with known simvastatin-induced myopathy ranged between 61% (for fluvastatin) and 81% (for rosuvastatin).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback